Dorian Therapeutics Is A Biotechnology Company Based In San Carloscaliforniafocused On Regenerative Medicinefounded In 2018 By Maddalena Adornophdand Benedetta Di Robilantphdthe Company Specializes In Developing Senoblockersthese Innovative Therapeutics Aim To Counteract Aging By Inhibiting Cellular Senescence And Enhancing Tissue Regeneration The Company Is Engaged In Pre Clinical Research To Advance Its Senoblocker Technology Toward Clinical Trialsdorian Therapeutics Has Received Support From Notable Investors And Incubatorsincluding Y Combinatorstartxthe Longevity Fundblumberg Capitaland Pacific8With A Small Team Of Around 8 9 Employeesdorian Therapeutics Is Dedicated To Addressing Age Related Diseases Through Its Pioneering Research And Development Efforts
